Bose, A., Hartmann, M., Henkes, H., Liu, H.M., Teng, M.M.H., Szikora, I., Berlis, A., Reul, J., Yu, S.C.H., Forsting, M., Lui, M., Lim, W. and Sit, S.P. (2007) A Novel, Self-Expanding, Nitinol Stent in Medically Refractory Intracranial Atherosclerotic Stenoses. Stroke, 38, 1531-1537.
http://dx.doi.org/10.1161/STROKEAHA.106.477711

has been cited by the following article:

• TITLE: Intracranial Atherosclerosis: The Natural History and Management Strategies

  AUTHORS: Ossama Mansour, Martin Schumacher, Mohammad A. Farrag, Foad Abd-Allah

  KEYWORDS: Intracranial Atherosclerosis, Medical Therapy, Endovascular Treatment

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.4 No.7, June 12, 2014

  ABSTRACT: Intracranial atherosclerotic disease (ICAD) represents a major cause of stroke and transient ischemic attacks. The prevalence and natural course of ICAD are closely related to race and ethnicity. The best treatment for ICAD is a crucial issue; data from recent trials indicate that aggressive medical management and life style modifications are better than endovascular treatments for prevention of recurrent stroke in high-risk patients with ICAD. Endovascular treatment is still an option for subgroup of patients who are not responded to optimal medical therapy.